The biotechnology company released an organ-on-chip platform using primate cells to model immune-related diseases for drug ...
The integrated organ-on-chip platform offers 10--100x cost efficiency and 80% reduction in animal use, bridging the gap between preclinical NHP research and human clinical success. SUZHOU, China, SAN ...
The integrated organ-on-chip platform offers 10-100x cost efficiency and 80% reduction in animal use, bridging the gap betwee ...
Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.
Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists ...
An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...
GSK has claimed approval in the EU for Exdensur, a long-acting respiratory drug that is considered one of its top growth prospects. The approval of Exdensur (depemokimab) for severe asthma and chronic ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Deep cuts from accidents or surgeries require stitches, typically followed by oral anti-inflammatory medications like ...
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
Today, the U.S. Food and Drug Administration approved the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 micrograms per actuation, for the maintenance treatment of asthma ...
Why didn’t you recommend one of the at-home kits for the person with Lynch syndrome who had a bad reaction during her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results